Search Results - "Lichtfuss, Gregor"

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    HIV infection induces age-related changes to monocytes and innate immune activation in young men that persist despite combination antiretroviral therapy by HEARPS, Anna C, MAISA, Anna, CHENG, Wan-Jung, ANGELOVICH, Thomas A, LICHTFUSS, Gregor F, PALMER, Clovis S, LANDAY, Alan L, JAWOROWSKI, Anthony, CROWE, Suzanne M

    Published in AIDS (London) (24-04-2012)
    “…To compare the impact of HIV infection and healthy ageing on monocyte phenotype and function and determine whether age-related changes induced by HIV are…”
    Get full text
    Journal Article
  2. 2

    Virologically suppressed HIV patients show activation of NK cells and persistent innate immune activation by Lichtfuss, Gregor F, Cheng, Wan-Jung, Farsakoglu, Yagmur, Paukovics, Geza, Rajasuriar, Reena, Velayudham, Pushparaj, Kramski, Marit, Hearps, Anna C, Cameron, Paul U, Lewin, Sharon R, Crowe, Suzanne M, Jaworowski, Anthony

    Published in The Journal of immunology (1950) (01-08-2012)
    “…FcRγ is an ITAM-containing adaptor required for CD16 signaling and function in NK cells. We have previously shown that NK cells from HIV patients receiving…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    HIV inhibits early signal transduction events triggered by CD16 cross-linking on NK cells, which are important for antibody-dependent cellular cytotoxicity by Lichtfuss, Gregor F., Meehan, Aislin C., Cheng, Wan‐Jung, Cameron, Paul U., Lewin, Sharon R., Crowe, Suzanne M., Jaworowski, Anthony

    Published in Journal of leukocyte biology (01-01-2011)
    “…Defective NK cell ADCC in whole blood from HIV‐infected patients due to impaired early signaling in response to CD16 surface receptor cross‐linking…”
    Get full text
    Journal Article
  6. 6

    Biomarkers of immune dysfunction following combination antiretroviral therapy for HIV infection by Lichtfuss, Gregor F, Hoy, Jennifer, Rajasuriar, Reena, Kramski, Marit, Crowe, Suzanne M, Lewin, Sharon R

    Published in Biomarkers in medicine (01-04-2011)
    “…Combination antiretroviral therapy (cART) has significantly reduced morbidity and mortality of HIV-infected patients, yet their life expectancy remains reduced…”
    Get more information
    Journal Article
  7. 7

    Anti‐HIV‐1 antibody‐dependent cellular cytotoxicity mediated by hyperimmune bovine colostrum IgG by Kramski, Marit, Lichtfuss, Gregor F., Navis, Marjon, Isitman, Gamze, Wren, Leia, Rawlin, Grant, Center, Rob J., Jaworowski, Anthony, Kent, Stephen J., Purcell, Damian F. J.

    Published in European journal of immunology (01-10-2012)
    “…Antibodies with antibody‐dependent cellular cytotoxicity (ADCC) activity play an important role in protection against HIV‐1 infection, but generating…”
    Get full text
    Journal Article
  8. 8

    Rapid detection of anti-Vaccinia virus neutralizing antibodies by Kramski, Marit, Drozd, Anna, Lichtfuss, Gregor F, Dabrowski, Piotr W, Ellerbrok, Heinz

    Published in Virology journal (25-03-2011)
    “…Increasing infections with Monkeypox and Cowpox viruses pose a continuous and growing threat to human health. The standard method for detecting poxvirus…”
    Get full text
    Journal Article
  9. 9

    Prospective Therapeutic Applications of Platelet Extracellular Vesicles by Johnson, Jancy, Wu, Yu-Wen, Blyth, Chantelle, Lichtfuss, Gregor, Goubran, Hadi, Burnouf, Thierry

    Published in Trends in biotechnology (Regular ed.) (01-06-2021)
    “…There is much interest in the use of extracellular vesicles (EVs) as a subcellular therapy for regenerative medicine and drug delivery. Blood-borne platelets…”
    Get full text
    Journal Article
  10. 10

    Microfluidic resistive pulse sensing (MRPS) validated as a rapid and practical method for evaluating EV enrichment techniques by Fraikin, Jean-Luc, Johnson, Jancy, Dixon, Ian, Kalionis, Bill, Lichtfuss, Gregor

    Published in Journal of extracellular vesicles (01-01-2018)
    “…Background: Delivering commercial value for extracellular vesicles (EVs) as therapeutics requires improved techniques for their isolation and enrichment…”
    Get full text
    Journal Article
  11. 11

    Anti‐ HIV ‐1 antibody‐dependent cellular cytotoxicity mediated by hyperimmune bovine colostrum I g G by Kramski, Marit, Lichtfuss, Gregor F., Navis, Marjon, Isitman, Gamze, Wren, Leia, Rawlin, Grant, Center, Rob J., Jaworowski, Anthony, Kent, Stephen J., Purcell, Damian F. J.

    Published in European journal of immunology (01-10-2012)
    “…Antibodies with antibody‐dependent cellular cytotoxicity ( ADCC ) activity play an important role in protection against HIV ‐1 infection, but generating…”
    Get full text
    Journal Article
  12. 12

    Characterization of extracellular vesicles derived from two populations of human placenta derived mesenchymal stem/stromal cells by Khanabdali, R., Shojaee, M., Johnson, J., Law, S., Whitmore, M., Lim, M., Schoppet, M., Silva, A., James, P., Kalionis, B., Dixon, I., Lichtfuss, G. Gregor, Tester, A.

    Published in Cytotherapy (Oxford, England) (01-05-2020)
    “…Growing evidence shows that extracellular vesicles (EVs) are responsible for the therapeutic effect of stem cell therapy. EVs are a promising, potential…”
    Get full text
    Journal Article